Status:

COMPLETED

Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT

Lead Sponsor:

LHL Helse

Collaborating Sponsors:

The norwegian association for heart and lung patients

Conditions:

COPD

Eligibility:

All Genders

Phase:

NA

Brief Summary

The aim of the study is to evaluate effects of supplementary oxygen during exercise on dyspnoea and exercise tolerance in COPD-patients given long-time oxygen treatment

Eligibility Criteria

Inclusion

  • COPD patients (male/female)given long-term oxygen treatment
  • Able to perform two separate walking tests

Exclusion

  • Severe heart failure

Key Trial Info

Start Date :

October 1 2005

Trial Type :

INTERVENTIONAL

End Date :

April 1 2007

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00249093

Start Date

October 1 2005

End Date

April 1 2007

Last Update

April 13 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Glittreklinikken

Hakadal, Hakadal, Norway, 1485